282 related articles for article (PubMed ID: 27053529)
21. ITP and international guidelines: what do we know, what do we need?
Rodeghiero F; Ruggeri M
Presse Med; 2014 Apr; 43(4 Pt 2):e61-7. PubMed ID: 24656296
[TBL] [Abstract][Full Text] [Related]
22. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
23. Treatment of primary and secondary immune thrombocytopenia.
Kado R; McCune WJ
Curr Opin Rheumatol; 2019 May; 31(3):213-222. PubMed ID: 30920453
[TBL] [Abstract][Full Text] [Related]
24. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
25. Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate.
Stasi R; Newland A; Thornton P; Pabinger I
Ann Hematol; 2010 Dec; 89(12):1185-95. PubMed ID: 20842501
[TBL] [Abstract][Full Text] [Related]
26. The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.
Palandri F; Polverelli N; Catani L; Sollazzo D; Romano M; Levorato M; Vianelli N
Am J Hematol; 2014 Nov; 89(11):1047-50. PubMed ID: 25103500
[TBL] [Abstract][Full Text] [Related]
27. Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab.
Zaja F; Marin L; Chiozzotto M; Puglisi S; Volpetti S; Fanin R
Am J Hematol; 2012 Mar; 87(3):321-3. PubMed ID: 22190262
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic options for adult patients with previously treated immune thrombocytopenia - a systematic review and network meta-analysis.
Yang R; Lin L; Yao H; Ji O; Shen Q
Hematology; 2019 Dec; 24(1):290-299. PubMed ID: 30661482
[TBL] [Abstract][Full Text] [Related]
29. Melatonin makes splenectomy unnecessary in two patients with idiopathic thrombocytopenic purpura refractory to corticosteroids.
Todisco M
J Pineal Res; 2007 Sep; 43(2):214. PubMed ID: 17645700
[No Abstract] [Full Text] [Related]
30. Long-term efficacy of partial splenic embolization for the treatment of steroid-resistant chronic immune thrombocytopenia.
Togasaki E; Shimizu N; Nagao Y; Kawajiri-Manako C; Shimizu R; Oshima-Hasegawa N; Muto T; Tsukamoto S; Mitsukawa S; Takeda Y; Mimura N; Ohwada C; Takeuchi M; Sakaida E; Iseki T; Yoshitomi H; Ohtsuka M; Miyazaki M; Nakaseko C
Ann Hematol; 2018 Apr; 97(4):655-662. PubMed ID: 29332223
[TBL] [Abstract][Full Text] [Related]
31. Adult Primary Immune Thrombocytopenia: Spleen Histology Findings and Outcomes According to Rituximab Use Based on Analysis of 41 Cases.
Furudoï A; Rivière É; Lazaro E; Furudoï E; Viallard JF; Parrens M
Am J Surg Pathol; 2018 Mar; 42(3):401-412. PubMed ID: 29200102
[TBL] [Abstract][Full Text] [Related]
32. Treatment of immune thrombocytopenic purpura in children : current concepts.
Shad AT; Gonzalez CE; Sandler SG
Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
[TBL] [Abstract][Full Text] [Related]
33. Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on romiplostim and eltrombopag.
Chouhan JD; Herrington JD
Pharmacotherapy; 2010 Jul; 30(7):666-83. PubMed ID: 20575632
[TBL] [Abstract][Full Text] [Related]
34. Splenectomy in ITP: we keep removing a healthy functional organ.
Anguita E; Candel FJ; González-Del Castillo J; Martín-Sánchez FJ
Ann Hematol; 2016 Oct; 95(11):1911-2. PubMed ID: 27577110
[No Abstract] [Full Text] [Related]
35. [Cost-per-responder analysis comparing romiplostim to rituximab in the treatment of adult primary immune thrombocytopenia in Spain].
López MF; Mingot ME; Valcárcel D; Vicente García V; Perrin A; Campos Tapias I
Med Clin (Barc); 2015 May; 144(9):389-96. PubMed ID: 24565604
[TBL] [Abstract][Full Text] [Related]
36. [Idiopathic thrombocytopenic purpura (ITP) in children].
Rajantie J
Duodecim; 2011; 127(19):2081-6. PubMed ID: 22073540
[TBL] [Abstract][Full Text] [Related]
37. Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia.
Mahévas M; Gerfaud-Valentin M; Moulis G; Terriou L; Audia S; Guenin S; Le Guenno G; Salles G; Lambotte O; Limal N; Viallard JF; Cheze S; Tomowiak C; Royer B; Neel A; Debouverie O; Hot A; Durieu I; Perlat A; Cliquennois M; Deteix C; Michel M; Godeau B
Blood; 2016 Sep; 128(12):1625-30. PubMed ID: 27354722
[TBL] [Abstract][Full Text] [Related]
38. Immune thrombocytopenia in adults: an update.
Thota S; Kistangari G; Daw H; Spiro T
Cleve Clin J Med; 2012 Sep; 79(9):641-50. PubMed ID: 22949345
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone.
Oved JH; Lee CSY; Bussel JB
J Pediatr; 2017 Dec; 191():225-231. PubMed ID: 29173312
[TBL] [Abstract][Full Text] [Related]
40. Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature.
Al-Husban N; Al-Kuran O
J Med Case Rep; 2018 Jun; 12(1):147. PubMed ID: 29855343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
